6-K 1 ambevsapr4q14_6k.htm AMBEV REPORTS 2014 FOURTH QUARTER AND FULL YEAR RESULTS UNDER IFRS ambevsapr4q14_6k.htm - Generated by SEC Publisher for SEC Filing
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
FORM 6-K
 
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
 

For the month of February, 2015

Commission File Number 1565025

 

 

AMBEV S.A.
(Exact name of registrant as specified in its charter)
 

AMBEV S.A.
(Translation of Registrant's name into English)
 

Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor
04530-000 São Paulo, SP
Federative Republic of Brazil
(Address of principal executive office)
 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. 


Form 20-F ___X___ Form 40-F _______

 Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.  

Yes _______ No ___X____


 

Fourth Quarter and Full Year 2014 Results

February 26, 2015

Page 1

 

AMBEV REPORTS 2014 FOURTH QUARTER AND FULL YEAR RESULTS UNDER IFRS

São Paulo, February 26, 2015 – Ambev S.A. [BOVESPA: ABEV3; NYSE: ABEV] announces today its results for the fourth quarter and full year 2014. The following operating and financial information, unless otherwise indicated, is presented in nominal Reais and prepared according to International Financial Reporting Standards (IFRS), and should be read together with our quarterly financial information for the twelve-month period ended December 31, 2014 filed with the CVM and submitted to the SEC. For information about the 2013 Reference Base, used for comparison purposes in this document, please refer to page 21.

 

Operating and Financial Highlights 

 

Top line performance: Net revenues accelerated in 4Q14 and grew 11.5%, driven by top line growth in all of our operations (Brazil +10.4%, HILA-Ex +17.5%, LAS +18.7% and Canada +1.0%), leading to a 10.9% growth in FY 2014. Volumes in 4Q14 were up 0.3%, with positive contributions in Brazil Beer (+1.5%), HILA-Ex (+11.9%) and Canada (+0.3%), partially offset by a decline in Brazil CSD & NANC (-1.7%) and LAS (-2.9%), while Net Revenue per hectoliter (NR/hl) increased 11.2%, driven by our revenue management initiatives, the benefit of premium mix and the increased weight of direct distribution in Brazil. In the full year, our volumes increased 2.9% while NR/hl was up 7.8%.

Cost of Goods Sold (COGS): Our COGS increased 16.1% in 4Q14 and 12.9% in the full year, whereas on a per hectoliter basis, costs increased 15.8% and 9.8%, respectively. Our performance in the quarter was impacted by unfavorable currency hedges, higher inflation in Argentina, packaging mix in Brazil and industrial depreciation growth, partially offset by our commodities hedges and procurement savings initiatives.

Selling, General & Administrative (SG&A) expenses: SG&A expenses (excluding depreciation and amortization) were up 12.3% in the quarter and 11.7% in FY 2014. This year was marked by strong investments in sales & marketing initiatives related to the 2014 FIFA World Cup, mainly in Brazil. Along with that, higher distribution costs as a result of the increased weight of direct distribution in Brazil and inflation in Argentina were also important drivers of SG&A growth, partially offset by administrative expenses, which grew below inflation.

EBITDA, Gross margin and EBITDA margin: Our Normalized EBITDA grew 7.6% in 4Q14 and 7.5% in the full year, reaching R$ 6,801 million and R$ 18,276 million, respectively. Normalized EBITDA margin contracted 200 basis points to 55.6% in the quarter, fully explained by the R$ 300 million one-time gain related to recovery of restricted funds recorded in 4Q13. In the full year, our Normalized EBITDA margins were down 160bps to 48.0%.

Normalized Net Profit and EPS: Normalized Net Profit was R$ 4,722 million in 4Q14 and R$ 12,451 in FY 2014, up 8.9% versus 2013 driven by EBITDA growth, better financial results and a lower effective tax rate. Normalized Earnings Per Share (EPS) was R$ 0.29 in the quarter and R$ 0.77 in the full year.

Operating Cash generation and CAPEX: We generated R$ 9,016 million of cash from our operations in the quarter and R$ 18,781 million in FY 2014, a 7.5% increase versus 2013 mainly as a result of stronger operational performance and better working capital management. During the fourth quarter of 2014 capital expenditure reached R$ 1,276 million, leading to a R$ 4,493 million total capex in the year, of which R$ 3.1 billion were invested in Brazil.

Pay-out and Financial discipline: During 2014, we returned close to R$ 12.0 billion through dividends and IOC to shareholders, our biggest annual cash payout. Still in December 2014, we announced two additional IOC payments totaling R$ 3.5 billion that were fully paid during January 2015. On February 25th, we announced a buyback program totaling R$ 850 million that we expect to be fully executed in 2015. As of December 31th, 2014, our net cash position was R$ 7,713.3 million, not yet accounting for the distributions announced in December, 2014.

 

This press release segregates the impact of organic changes from those arising from changes in scope or currency translation. Scope changes represent the impact of acquisitions and divestitures, the start up or termination of activities or the transfer of activities between segments, curtailment gains and losses and year over year changes in accounting estimates and other assumptions that management does not consider as part of the underlying performance of the business. Unless stated, percentage changes in this press release are both organic and normalized in nature. Whenever used in this document, the term “normalized” refers to performance measures (EBITDA, EBIT, Profit, EPS) before special items adjustments. Special items are either income or expenses which do not occur regularly as part of the normal activities of the Company. They are presented separately because they are important for the understanding of the underlying sustainable performance of the Company due to their size or nature. Normalized measures are additional measures used by management and should not replace the measures determined in accordance with IFRS as indicators of the Company’s performance. Comparisons, unless otherwise stated, refer to the fourth quarter of 2013 (4Q13 Reference Base) or full year’2013 (FY13 Reference Base), as the case may be. Values in this release may not add up due to rounding.

 


 

Fourth Quarter and Full Year 2014 Results

February 26, 2015

Page 2

 

 

Financial highlights - Ambev consolidated

4Q13 Reference Base

 

% As

%

FY13 Reference Base

 

% As

%

 

 

R$ million

4Q14

Reported

Organic

FY14

Reported

Organic

Total volumes

49,326.7

49,572.0

0.5%

0.3%

166,468.3

171,765.7

3.2%

2.9%

Beer

35,605.9

36,084.7

1.3%

1.0%

120,110.4

124,767.4

3.9%

3.5%

CSD and NANC

13,720.8

13,487.3

-1.7%

-1.7%

46,357.9

46,998.3

1.4%

1.4%

 

     

 

     

 

Net sales

11,132.6

12,232.9

9.9%

11.5%

35,079.1

38,079.8

8.6%

10.9%

Gross profit

7,809.0

8,423.0

7.9%

9.6%

23,506.6

25,265.2

7.5%

9.9%

Gross margin

70.1%

68.9%

-120 bps

-130 bps

67.0%

66.3%

-70 bps

-60 bps

EBITDA

6,458.6

6,738.0

4.3%

6.9%

17,535.9

18,186.8

3.7%

7.1%

EBITDA margin

58.0%

55.1%

-290 bps

-240 bps

50.0%

47.8%

-220 bps

-170 bps

Normalized EBITDA

6,474.6

6,801.1

5.0%

7.6%

17,565.1

18,275.8

4.0%

7.5%

Normalized EBITDA margin

58.2%

55.6%

-260 bps

-200 bps

50.1%

48.0%

-210 bps

-160 bps

Profit

4,764.9

4,659.1

-2.2%

 

11,399.4

12,362.0

8.4%

 

Normalized profit

4,780.9

4,722.2

-1.2%

 

11,428.6

12,451.0

8.9%

 

EPS (R$/shares)

0.30

0.29

-3.2%

 

0.75

0.77

2.1%

 

Normalized EPS

0.30

0.29

-2.1%

 

0.76

0.77

2.0%

 


Note:
Earnings per share calculation is based on outstanding shares (total existing shares excluding shares held in treasury).

 

Management Comments 

2014 was a year of important achievements across the different geographies where we operate.

Particularly in Brazil, after a tough 2013, we started the year with a plan to once again build momentum not only for 2014 but for the years to come by (i) growing our top line in a solid way with a better balance between volume and price and by (ii) accelerating our investments behind our brands, leveraging the 2014 FIFA World Cup platform, to support our future growth.

As discussed in our 3Q14 results announcement, despite the softer macroeconomic environment experienced in the third quarter following the 2014 FIFA World Cup, we maintained our plan, confident that our strategy was the right one not only to face the short term challenges but to better position ourselves for the future. Indeed, we saw Brazil net revenue and EBITDA reaccelerating in the 4Q.

When we look at our commercial execution in Brazil, we are not only pleased with the performance in 2014 but confident we leave the year better positioned for 2015 onwards:

·   In 2014, we embraced a dream of making the best FIFA World Cup ever, leveraging this very unique opportunity to create memorable moments, connecting with our consumers through life lasting experiences. Along with the 1.4MM hl one time volume benefit experienced mainly during the 2Q, Brahma and Budweiser, official beer brands of the event, had outstanding visibility and engaged with consumer through complete 360o activations, building strong brand equity. Budweiser gained 500bps of market share in the premium segment during the event and retained most of it since then.

·   Our premium volumes grew almost 20% in the full year, with Original, Budweiser and Stella Artois all growing double digits, as we significantly improved our execution. Premium now represents around 8% of our volumes and we are confident it will continue to grow well ahead the industry average;

·   With our innovations, mainly represented by Brahma 0.0%, Skol Beats Extreme and Skol Beats Senses, we started to capture volume opportunities in occasions where our share of throat has historically been low. Launched in 2013, Brahma 0.0% is now the leading brand in the non alcoholic beer market and already represents around 1% of our total beer volumes in Brazil;

·   Within CSD, with a great performance of both Guaraná Antarctica and Pepsi, we finished 2014 with the all-time high annual market share (18.8%).

In Central America and the Caribbean (“HILA-Ex”), we had another year of strong top line growth and EBITDA margin expansion, while focusing on both organic and non-organic growth strategies.

In Latin America South (LAS), with Argentina still facing a very challenging macroeconomic environment, we continued to pursue a solid top line growth, strengthening the equity of our brands, while protecting our profitability.

 


 

Fourth Quarter and Full Year 2014 Results

February 26, 2015

Page 3

 

And in Canada, we reignited our market share growth with Corona as we took over the brand in March and improved our EBITDA performance along the year.

Looking at our divisional performance:

·   Brazil. Our top line reaccelerated, growing 10.4% in the 4Q and 10.6% in the full year, reaching the upper end of our original guidance (high single to low double digits top line growth in the full year).

Even facing the hardest comparable base of the year, given the R$ 300 million one time gain related to a recovery of restricted funds recorded in the 4Q13, our EBITDA performance also reaccelerated, reaching R$ 4,814 million in the 4Q14 (+5.4%) with an EBITDA margin of 60.9% (-290bps margin compression fully explained by the hard comparable base). In the full year, our Brazilian operations delivered an EBITDA of R$ 12,725 (+5.3%), with an EBITDA margin of 52.2% (-260bps).

o Net revenue in Beer Brazil grew a strong 11.5% in the quarter, as (i) our NR/hl increased by a solid 9.8%, driven by our revenue management initiatives, the benefit of premium mix and increased weight of direct distribution; while (ii) our volumes were up 1.5%, driven by a +50bps market share growth (68.0% average in the quarter) and an industry growth of 0.6%, recovering from the decline observed in the 3Q14.

While committed to our strategy of finding a better balance between volume and price in the full year, we were able to increase our top line in a solid way in 2014. In the full year, our net revenue was up by 11.2% with a 4.7% volume increase and a 6.2% NR/hl growth.

o As for CSD & NANC Brazil, our net revenue increased by 4.9% in the quarter and 7.7% in the full year. Our volumes were down 1.7% in 4Q14, driven by a flattish industry (+0.3%) and a market share decline (-60bps, 18.4% in the quarter). In the year, our volumes grew 1.4% with an annual record market share of 18.8% (+40bps). Net revenue per hectoliter grew 6.8% in the quarter and 6.2% in 2014.

o Brazil COGS/hl grew 11.0% in the quarter, mainly driven by (i) higher industrial depreciation related to our capex investments; (ii) a higher FX hedge impact; and (iii) a negative impact from packaging mix; (iv) partially offset by commodities hedges and (v) procurement savings.

In the full year, our COGS/hl grew 9.1%. When excluded the packaging mix impact of the 2014 FIFA World Cup in the 2Q and 3Q, our COGS/hl would have grown mid single digits, in line with our guidance.

o Brazil SG&A grew 16.5% due to (i) sales & marketing expenses, lower on a sequential basis but double digits above last year, driven by investments behind our brands and acceleration of innovations and (ii) double digit distribution expenses growth driven by the increased weight of direct distribution.

In the full year, sales & marketing and distribution expenses grew double digits, while administrative expenses grew below inflation, in line with our guidance. Impacted by higher depreciation, up +23% in the full year, our SG&A (+13.7%) was slightly above the upper end of our guidance (high single to low double digits SG&A growth).

·   HILA-Ex. EBITDA for the region totaled R$ 269.3 million in the quarter (+26.8%) and EBITDA margin grew 290 bps to 38.4%. In the full year, we delivered R$ 697.7 million of EBITDA, which represents +23.1% compared to last year, and an EBITDA margin of 33.4% (+240 bps).

o The strong performance witnessed during the first nine months continued into 4Q14 as we had another quarter of solid top line growth and EBITDA margin expansion. Net revenues grew in all countries across the region, as we continue to gain share of alcoholic beverage in the Dominican Republic and expand market share in Guatemala. NR increased 17.5% in the quarter driven by volume growth (+11.9%) and net revenues per hectoliter increase of 5.0%. Our plan for the region remains on track and we maintain our focus on top line opportunities as well as margin expansion.

·   LAS. EBITDA for the region totaled R$ 1,234.3 million in 4Q14 (+14.6%). Our gross margin and EBITDA margin contracted 430 bps and 190 bps to 64.4% and 50.8%, respectively. In the full year, our EBITDA increased 17.5% and our gross and EBITDA margins were slightly down, decreasing 20 bps each.

 

 


 

Fourth Quarter and Full Year 2014 Results

February 26, 2015

Page 4

 

o After expanding during the previous quarter, volumes returned to negative territory in 4Q14, mainly due to industry contraction in Argentina as the tough macroeconomic environment persists in the country. Despite this adverse scenario, in the full year we had a solid top line performance in the region (+17.9%), by protecting our volumes (FY 2014, LAS Beer 0.0%; LAS CSD & NANC -0.6%) and successfully implementing our revenue management initiatives. During the quarter, we launched Mixxtail Mojito in Argentina, a ready to drink liquid, as innovation continues to play an important role in capturing volume opportunities in different consumption occasions.

·   Canada. EBITDA grew 3.1% in the quarter, reaching R$ 483.7 million. Gross and EBITDA margins expanded 80 bps each to 70.5% and 40.6%, respectively.

o Volumes increased 0.3% in the quarter driven by industry expansion, with a positive impact from weather. On a reported basis, given Corona addition to our portfolio, volumes grew 4.6% in the quarter, achieving an estimated market share of 41.7% in 4Q14. NR/hl increased 0.7% during the quarter, as a result of our revenue management strategies and commitment to drive premium brands, as we continue to deliver strong results with brands like Shock Top, which has been one of the fastest-growing brands in Canada during 2014. At the same time, we leveraged our cost management strengths once again to improve both COGS and SG&A, enhancing our EBITDA performance quarter over quarter during 2014 (1Q -16.4%, 2Q -0.3%, 3Q +2.2%, 4Q +3.1%).

 

 

Outlook 

 

Every year is a new start. And it is great to start 2015 from the base that we built in 2014.

Particularly in Brazil, despite the continued challenging macroeconomic environment, we remain excited with our commercial strategy and the opportunities we see going forward:

·   After 4 years of industry volumes being pressured by real tax increases, we have a new tax model approved, and do not expect any material impact on volumes driven from that in the years to come;

·   As a strong competitive advantage and in order to drive superior top line performance in a sustainable way, we will continue to focus on elevating our core brands, through innovations and a complete 360o sales & marketing approach, while providing affordability through our winning packaging initiatives and revenue management strategy;

·   Premium should continue to grow well ahead of the industry and we have a clear game plan to lead this growth;

·   With our innovations in beer and “near beer”, we see a significant volume opportunity to be captured by winning a bigger “share of throat” of the total alcohol beverage space;

·   As we improve our understanding of consumer need states, we are able (i) to provide a better execution in the on trade through a truly experiential activation and also (ii) to enhance our strategy in the in home occasion while also focusing on a better shopper experience in the off trade channel;

·   Within CSD, after a strong performance of Pepsi and Guaraná Antarctica in 2014, we will continue to evolve our commercial strategy by:

o Connecting with consumers through relevant platforms. In 2015, Pepsi will be the official sponsor of Rock in Rio, the biggest music festival in Brazil;

o Driving innovations, such as the new Guaraná Antarctica Black;

o Addressing affordability through our packaging strategies, mainly the 1-liter returnable glass bottle.

Being an intrinsic part of our culture, we will keep looking for cost management opportunities, mainly in our fixed and “non-working money” base, while continuously investing in our brands and supporting our commercial initiatives.

With that in mind, we expect:

·   Our top line in Brazil to grow mid to high single digits in the full year;

 


 

Fourth Quarter and Full Year 2014 Results

February 26, 2015

Page 5

 

·   Our cash COGS in Brazil to grow mid to high single digits in the full year, including the impact of the devaluation of the Brazilian Real during 2014 (our average implied foreign exchange hedge rate for 2015 is 2.31 BRL/USD, which compares to 2.19 BRL/USD in 2014);

·   Brazil cash SG&A to grow below inflation in the full year;

·   Capex in Brazil is foreseen to be up to 2014 levels.

Across other geographies, we remain cautious about the Argentinean macroeconomic scenario, however we remain not only committed to our long-term goals but also confident in our ability to drive solid and profitable growth in the LAS region. In Canada, we will continue pursuing a healthy top line growth with superior profitability, not only with Corona but with our focus brands as well. And in Central America and the Caribbean (“HILA-Ex”), we expect another year of solid top line and EBITDA performance while we balance our plan in the region through organic and non-organic growth strategies.

 

 

 

 


 

Fourth Quarter and Full Year 2014 Results

February 26, 2015

Page 6

 

Ambev Consolidated Income Statement 
 

Consolidated income statement

4Q13 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

4Q14

Reported

Organic

Net revenue

11,132.6

69.6

(262.9)

1,293.6

12,232.9

9.9%

11.5%

Cost of goods sold (COGS)

(3,323.6)

(29.3)

83.4

(540.3)

(3,809.8)

14.6%

16.1%

Gross profit

7,809.0

40.2

(179.5)

753.3

8,423.0

7.9%

9.6%

Selling, general and administrative (SG&A)

(2,600.3)

(47.5)

70.6

(386.4)

(2,963.6)

14.0%

14.6%

Other operating income

743.0

(5.8)

(29.5)

(44.6)

663.1

-10.8%

-6.0%

Normalized operating income
(normalized EBIT)

5,951.7

(13.1)

(138.4)

322.3

6,122.5

2.9%

5.4%

Exceptional items above EBIT

(16.0)

 

0.9

(48.0)

(63.2)

294.0%

299.5%

Net finance results

(558.9)

 

 

 

(587.5)

5.1%

 

Share of results of associates

5.7

 

 

 

4.2

-27.5%

 

Income tax expense

(617.6)

 

 

 

(816.9)

32.3%

 

Profit

4,764.9

 

 

 

4,659.1

-2.2%

 

Attributable to Ambev holders

4,673.7

 

 

 

4,538.4

-2.9%

 

Attributable to non-controlling interests

91.2

 

 

 

120.7

32.3%

 

Normalized profit

4,780.9

 

 

 

4,722.2

-1.2%

 

Attributable to Ambev holders

4,689.8

 

 

 

4,601.6

-1.9%

 

 

 

 

 

 

 

 

 

Normalized EBITDA

6,474.6

(18.3)

(148.9)

493.8

6,801.1

5.0%

7.6%

 

Consolidated income statement

FY13 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

FY14

Reported

Organic

Net revenue

35,079.1

314.0

(1,161.2)

3,847.8

38,079.8

8.6%

10.9%

Cost of goods sold (COGS)

(11,572.5)

(126.4)

395.8

(1,511.4)

(12,814.6)

10.7%

12.9%

Gross profit

23,506.6

187.6

(765.4)

2,336.5

25,265.2

7.5%

9.9%

Selling, general and administrative (SG&A)

(9,808.3)

(198.8)

292.9

(1,264.6)

(10,978.7)

11.9%

12.6%

Other operating income

1,761.7

(25.0)

(5.5)

(102.0)

1,629.2

-7.5%

-5.9%

Normalized operating income
(normalized EBIT)

15,460.0

(36.2)

(478.1)

969.9

15,915.6

2.9%

6.3%

Exceptional items above EBIT

(29.2)

 

3.8

(63.6)

(89.0)

204.8%

217.7%

Net finance results

(1,561.4)

 

 

 

(1,475.4)

-5.5%

 

Share of results of associates

11.4

 

 

 

17.4

52.2%

 

Income tax expense

(2,481.4)

 

 

 

(2,006.6)

-19.1%

 

Profit

11,399.4

 

 

 

12,362.0

8.4%

 

Attributable to Ambev holders

9,557.3

 

 

 

12,065.5

26.2%

 

Attributable to non-controlling interests

1,842.1

 

 

 

296.5

-83.9%

 

Normalized profit

11,428.6

 

 

 

12,451.0

8.9%

 

Attributable to Ambev holders

9,586.5

 

 

 

12,154.5

26.8%

 

 

 

 

 

 

 

 

 

Normalized EBITDA

17,565.1

(57.5)

(537.5)

1,305.8

18,275.8

4.0%

7.5%

 

 

 


 

Fourth Quarter and Full Year 2014 Results

February 26, 2015

Page 7

 

Ambev Consolidated Results 

                 

The combination of Ambev’s operations in Latin America North (LAN), Latin America South (LAS) and Canada’s business units, eliminating intercompany transactions, comprises our consolidated financial statements. The figures shown below are on an as-reported basis.

 

 


 

Fourth Quarter and Full Year 2014 Results

February 26, 2015

Page 8

 

Ambev Consolidated 

 

We delivered during the quarter R$ 6,801.1 million of Normalized EBITDA (+7.6%), with net revenues growing 11.5%, COGS rising 16.1% and SG&A (excluding depreciation and amortization) increasing 12.3%. In the full year, our EBITDA was up 7.5%.

 

Ambev results

4Q13 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

4Q14

Reported

Organic

Volume ('000 hl)

49,326.7

108.9

 

136.4

49,572.0

0.5%

0.3%

Net revenue

11,132.6

69.6

(262.9)

1,293.6

12,232.9

9.9%

11.5%

Net revenue/hl

225.7

0.9

(5.3)

25.5

246.8

9.3%

11.2%

COGS

(3,323.6)

(29.3)

83.4

(540.3)

(3,809.8)

14.6%

16.1%

COGS/hl

(67.4)

(0.4)

1.7

(10.7)

(76.9)

14.1%

15.8%

Gross profit

7,809.0

40.2

(179.5)

753.3

8,423.0

7.9%

9.6%

Gross margin

70.1%

 

 

 

68.9%

-120 bps

-130 bps

SG&A excl. deprec.&amort.

(2,443.7)

(52.7)

62.2

(306.4)

(2,740.6)

12.2%

12.3%

SG&A deprec.&amort.

(156.7)

5.2

8.4

(80.0)

(223.0)

42.4%

52.8%

SG&A total

(2,600.3)

(47.5)

70.6

(386.4)

(2,963.6)

14.0%

14.6%

Other operating income

743.0

(5.8)

(29.5)

(44.6)

663.1

-10.8%

-6.0%

Normalized EBIT

5,951.7

(13.1)

(138.4)

322.3

6,122.5

2.9%

5.4%

Normalized EBIT margin

53.5%

 

 

 

50.0%

-350 bps

-290 bps

Normalized EBITDA

6,474.6

(18.3)

(148.9)

493.8

6,801.1

5.0%

7.6%

Normalized EBITDA margin

58.2%

 

 

 

55.6%

-260 bps

-200 bps

 

Ambev results

FY13 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

FY14

Reported

Organic

Volume ('000 hl)

166,468.3

492.0

 

4,805.4

171,765.7

3.2%

2.9%

Net revenue

35,079.1

314.0

(1,161.2)

3,847.8

38,079.8

8.6%

10.9%

Net revenue/hl

210.7

1.3

(6.8)

16.5

221.7

5.2%

7.8%

COGS

(11,572.5)

(126.4)

395.8

(1,511.4)

(12,814.6)

10.7%

12.9%

COGS/hl

(69.5)

(0.6)

2.3

(6.8)

(74.6)

7.3%

9.8%

Gross profit

23,506.6

187.6

(765.4)

2,336.5

25,265.2

7.5%

9.9%

Gross margin

67.0%

 

 

 

66.3%

-70 bps

-60 bps

SG&A excl. deprec.&amort.

(9,144.3)

(220.1)

262.4

(1,099.2)

(10,201.2)

11.6%

11.7%

SG&A deprec.&amort.

(663.9)

21.3

30.5

(165.4)

(777.5)

17.1%

25.7%

SG&A total

(9,808.3)

(198.8)

292.9

(1,264.6)

(10,978.7)

11.9%

12.6%

Other operating income

1,761.7

(25.0)

(5.5)

(102.0)

1,629.2

-7.5%

-5.9%

Normalized EBIT

15,460.0

(36.2)

(478.1)

969.9

15,915.6

2.9%

6.3%

Normalized EBIT margin

44.1%

 

 

 

41.8%

-230 bps

-180 bps

Normalized EBITDA

17,565.1

(57.5)

(537.5)

1,305.8

18,275.8

4.0%

7.5%

Normalized EBITDA margin

50.1%

 

 

 

48.0%

-210 bps

-160 bps

 

 

 


 

Fourth Quarter and Full Year 2014 Results

February 26, 2015

Page 9

 

Latin America North (LAN) 

Our LAN region includes Beer Brazil, CSD & NANC Brazil and HILA-Ex operations. LAN EBITDA for the quarter totaled R$ 5,083.2 million (+6.3%), reaching R$ 13,422.7 million (+6.1%) in FY2014.

 

LAN results

4Q13 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

4Q14

Reported

Organic

Volume ('000 hl)

35,768.3

17.5

 

459.2

36,245.0

1.3%

1.3%

Net revenue

7,714.8

0.3

51.4

842.8

8,609.2

11.6%

10.9%

Net revenue/hl

215.7

(0.1)

1.4

20.5

237.5

10.1%

9.5%

COGS

(2,277.6)

(0.1)

(25.3)

(290.5)

(2,593.5)

13.9%

12.8%

COGS/hl

(63.7)

0.0

(0.7)

(7.2)

(71.6)

12.4%

11.3%

Gross profit

5,437.2

0.2

26.2

552.3

6,015.7

10.6%

10.2%

Gross margin

70.5%

 

 

 

69.9%

-60 bps

-50 bps

SG&A excl. deprec.&amort.

(1,663.8)

(0.0)

(13.0)

(226.9)

(1,903.7)

14.4%

13.6%

SG&A deprec.&amort.

(117.5)

 

(0.8)

(45.9)

(164.2)

39.7%

39.1%

SG&A total

(1,781.3)

(0.0)

(13.8)

(272.8)

(2,067.9)

16.1%

15.3%

Other operating income

734.2

 

(0.1)

(107.1)

627.0

-14.6%

-14.6%

Normalized EBIT

4,390.0

0.2

12.3

172.4

4,574.8

4.2%

3.9%

Normalized EBIT margin

56.9%

 

 

 

53.1%

-380 bps

-360 bps

Normalized EBITDA

4,767.0

0.2

16.3

299.7

5,083.2

6.6%

6.3%

Normalized EBITDA margin

61.8%

 

 

 

59.0%

-280 bps

-260 bps

 

LAN results

FY13 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

FY14

Reported

Organic

Volume ('000 hl)

120,415.4

38.8

 

4,964.1

125,418.3

4.2%

4.1%

Net revenue

23,767.4

0.3

111.4

2,591.6

26,470.7

11.4%

10.9%

Net revenue/hl

197.4

(0.1)

0.9

12.9

211.1

6.9%

6.5%

COGS

(7,727.3)

(0.1)

(56.5)

(1,023.6)

(8,807.5)

14.0%

13.2%

COGS/hl

(64.2)

0.0

(0.5)

(5.6)

(70.2)

9.4%

8.8%

Gross profit

16,040.1

0.2

54.9

1,568.0

17,663.2

10.1%

9.8%

Gross margin

67.5%

 

 

 

66.7%

-80 bps

-70 bps

SG&A excl. deprec.&amort.

(6,219.9)

(0.0)

(31.2)

(801.1)

(7,052.2)

13.4%

12.9%

SG&A deprec.&amort.

(505.8)

 

(1.7)

(93.1)

(600.7)

18.8%

18.4%

SG&A total

(6,725.7)

(0.0)

(33.0)

(894.2)

(7,652.9)

13.8%

13.3%

Other operating income

1,768.0

 

(0.6)

(146.4)

1,620.9

-8.3%

-8.3%

Normalized EBIT

11,082.4

0.2

21.3

527.4

11,631.3

5.0%

4.8%

Normalized EBIT margin

46.6%

 

 

 

43.9%

-270 bps

-260 bps

Normalized EBITDA

12,624.7

0.2

30.4

767.3

13,422.7

6.3%

6.1%

Normalized EBITDA margin

53.1%

 

 

 

50.7%

-240 bps

-230 bps

 

 

 

 


 

Fourth Quarter and Full Year 2014 Results

February 26, 2015

Page 10

 

Ambev Brazil 

 

We delivered R$ 4,813.9 million (+5.4%) of Normalized EBITDA in Brazil, with an EBITDA margin of 60.9%. Net revenue grew 10.4% in the quarter, with a volume increase of 0.6% and a NR/hl growth of 9.7%. COGS increased 11.7%, with COGS/hl up 11.0% mainly due to a higher industrial depreciation (+24.7%) while our cash COGS/hl grew 8.6%. Our SG&A (excluding depreciation and amortization) expenses increased 14.5% in the quarter. In the full year, our EBITDA reached R$ 12,724.9 million (+5.3%).

 

 

Ambev Brazil results

4Q13 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

4Q14

Reported

Organic

Volume ('000 hl)

33,666.0

 

  

207.0

33,873.0

0.6%

0.6%

Net revenue

7,162.0

 

  

746.2

7,908.2

10.4%

10.4%

Net revenue/hl

212.7

 

  

20.7

233.5

9.7%

9.7%

COGS

(2,041.4)

 

  

(238.6)

(2,280.0)

11.7%

11.7%

COGS/hl

(60.6)

 

  

(6.7)

(67.3)

11.0%

11.0%

Gross profit

5,120.6

 

  

507.6

5,628.2

9.9%

9.9%

Gross margin

71.5%

 

 

0.0%

71.2%

-30 bps

-30 bps

SG&A excl. deprec.&amort.

(1,520.5)

 

 

(219.9)

(1,740.5)

14.5%

14.5%

SG&A deprec.&amort.

(105.4)

 

  

(48.0)

(153.4)

45.6%

45.6%

SG&A total

(1,625.9)

 

  

(268.0)

(1,893.9)

16.5%

16.5%

Other operating income

737.9

 

  

(112.5)

625.4

-15.2%

-15.2%

Normalized EBIT

4,232.6

 

  

127.2

4,359.8

3.0%

3.0%

Normalized EBIT margin

59.1%

  

 

0.0%

55.1%

-400 bps

-400 bps

Normalized EBITDA

4,567.6

 

 

246.2

4,813.9

5.4%

5.4%

Normalized EBITDA margin

63.8%

  

 

0.0%

60.9%

-290 bps

-290 bps

 

Ambev Brazil results

FY13 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

FY14

Reported

Organic

Volume ('000 hl)

113,148.0

  

  

4,360.9

117,508.9

3.9%

3.9%

Net revenue

22,040.8

  

  

2,342.0

24,382.8

10.6%

10.6%

Net revenue/hl

194.8

   

  

12.7

207.5

6.5%

6.5%

COGS

(6,911.8)

  

  

(921.4)

(7,833.2)

13.3%

13.3%

COGS/hl

(61.1)

  

  

(5.6)

(66.7)

9.1%

9.1%

Gross profit

15,129.0

  

  

1,420.6

16,549.6

9.4%

9.4%

Gross margin

68.6%

  

 

0.0%

67.9%

-70 bps

-70 bps

SG&A excl. deprec.&amort.

(5,746.6)

  

  

(743.9)

(6,490.5)

12.9%

12.9%

SG&A deprec.&amort.

(458.8)

  

  

(106.6)

(565.4)

23.2%

23.2%

SG&A total

(6,205.4)

  

  

(850.5)

(7,055.9)

13.7%

13.7%

Other operating income

1,775.4

  

  

(151.5)

1,623.9

-8.5%

-8.5%

Normalized EBIT

10,699.0

  

  

418.7

11,117.6

3.9%

3.9%

Normalized EBIT margin

48.5%

  

 

0.0%

45.6%

-290 bps

-290 bps

Normalized EBITDA

12,082.7

  

  

642.3

12,724.9

5.3%

5.3%

Normalized EBITDA margin

54.8%

  

 

0.0%

52.2%

-260 bps

-260 bps

 

 


 

Fourth Quarter and Full Year 2014 Results

February 26, 2015

Page 11

 

Beer Brazil 

 

In the 4Q14, EBITDA for Beer Brazil was R$ 4,088.9 million (+5.9%) with an EBITDA margin of 61.0%.

Beer Brazil net revenue grew 11.5% in the quarter, driven by both volume and net revenue per hectoliter growth. While the macro economic environment continued to be soft, industry volumes were slightly up (+0.6%) and we had another quarter of market share growth (+50bps year over year), leading to a 1.5% volume increase. Our NR/hl was up by a solid 9.8% in the quarter, driven by our revenue management strategy, the benefit of premium mix and the increased weight of direct distribution.

COGS/hl was up 13.7%, mainly driven by (i) a 32.1% increase in industrial depreciation, related to our capex investments; (ii) a higher FX hedge impact; and (iii) a negative impact from packaging mix; (iv) partially offset by the benefit of lower commodities hedges and (v) procurement savings. SG&A (excluding depreciation and amortization) expenses were 17.0% above last year mainly as a result of higher sales and marketing expenses, albeit lower on a sequential basis, and higher logistic expenses, related to the increased weight of our direct distribution.

 

Beer Brazil results

4Q13 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

4Q14

Reported

Organic

Volume ('000 hl)

24,646.2

  

  

363.0

25,009.2

1.5%

1.5%

Net revenue

6,011.7

 

  

689.4

6,701.1

11.5%

11.5%

Net revenue/hl

243.9

 

  

24.0

267.9

9.8%

9.8%

COGS

(1,585.9)

 

  

(243.8)

(1,829.7)

15.4%

15.4%

COGS/hl

(64.3)

 

  

(8.8)

(73.2)

13.7%

13.7%

Gross profit

4,425.8

  

  

445.6

4,871.4

10.1%

10.1%

Gross margin

73.6%

  

 

 

72.7%

-90 bps

-90 bps

SG&A excl. deprec.&amort.

(1,336.0)

  

  

(227.7)

(1,563.7)

17.0%

17.0%

SG&A deprec.&amort.

(79.8)

  

  

(38.9)

(118.7)

48.8%

48.8%

SG&A total

(1,415.8)

  

  

(266.6)

(1,682.4)

18.8%

18.8%

Other operating income

574.8

  

  

(53.2)

521.7

-9.2%

-9.2%

Normalized EBIT

3,584.8

  

 

125.9

3,710.7

3.5%

3.5%

Normalized EBIT margin

59.6%

  

 

 

55.4%

-420 bps

-420 bps

Normalized EBITDA

3,861.1

  

  

227.8

4,088.9

5.9%

5.9%

Normalized EBITDA margin

64.2%

  

 

 

61.0%

-320 bps

-320 bps

 

Beer Brazil results

FY13 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

FY14

Reported

Organic

Volume ('000 hl)

82,973.9

  

  

3,930.0

86,903.9

4.7%

4.7%

Net revenue

18,407.2

  

 

2,061.5

20,468.6

11.2%

11.2%

Net revenue/hl

221.8

  

  

13.7

235.5

6.2%

6.2%

COGS

(5,323.7)

  

  

(838.7)

(6,162.4)

15.8%

15.8%

COGS/hl

(64.2)

  

  

(6.7)

(70.9)

10.5%

10.5%

Gross profit

13,083.4

  

  

1,222.8

14,306.2

9.3%

9.3%

Gross margin

71.1%

  

 

 

69.9%

-120 bps

-120 bps

SG&A excl. deprec.&amort.

(5,061.6)

  

  

(725.7)

(5,787.3)

14.3%

14.3%

SG&A deprec.&amort.

(346.8)

  

  

(87.6)

(434.4)

25.3%

25.3%

SG&A total

(5,408.4)

  

  

(813.4)

(6,221.8)

15.0%

15.0%

Other operating income

1,409.8

  

  

(80.2)

1,329.6

-5.7%

-5.7%

Normalized EBIT

9,084.8

  

  

329.2

9,414.0

3.6%

3.6%

Normalized EBIT margin

49.4%

  

 

 

46.0%

-340 bps

-340 bps

Normalized EBITDA

10,229.8

  

    

514.7

10,744.4

5.0%

5.0%

Normalized EBITDA margin

55.6%

  

 

 

52.5%

-310 bps

-310 bps

 

 


 

Fourth Quarter and Full Year 2014 Results

February 26, 2015

Page 12

 

CSD & NANC Brazil 

 

In Brazil CSD & NANC, EBITDA was R$ 724.9 million (+2.6%) in the 4Q14, with an EBITDA margin of 60.1%.

Net revenue increased 4.9% in the quarter with a volume decline of 1.7% more than offset by a strong NR/hl growth of 6.8%. We estimate the CSD industry was up by 0.3%, also impacted by the soft consumer environment, while our market share was down 60pbs to 18.4%. On the other hand, the NANC segment continued to outperform, growing double digits in the period. In January, we launched Guaraná Antarctica Black, a line extension of Guaraná Antartica, and Hello, a flavored water, further enhancing our product portfolio.

COGS per hectoliter grew 0.6% driven by unfavorable currency hedges almost fully offset by lower commodity costs and procurement savings. SG&A was up 0.7% as higher logistic expenses, driven by increased weight of our own distribution, and higher depreciation expenses were offset by lower sales & marketing and administrative expenses.

 

CSD&Nanc Brazil results

4Q13 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

4Q14

Reported

Organic

Volume ('000 hl)

9,019.9

  

  

(156.0)

8,863.8

-1.7%

-1.7%

Net revenue

1,150.3

  

  

56.8

1,207.1

4.9%

4.9%

Net revenue/hl

127.5

  

  

8.7

136.2

6.8%

6.8%

COGS

(455.5)

  

  

5.2

(450.3)

-1.1%

-1.1%

COGS/hl

(50.5)

  

  

(0.3)

(50.8)

0.6%

0.6%

Gross profit

694.8

  

  

62.0

756.8

8.9%

8.9%

Gross margin

60.4%

  

 

 

62.7%

230 bps

230 bps

SG&A excl. deprec.&amort.

(184.5)

  

  

7.7

(176.8)

-4.2%

-4.2%

SG&A deprec.&amort.

(25.6)

  

  

(9.1)

(34.7)

35.7%

35.7%

SG&A total

(210.1)

  

  

(1.4)

(211.5)

0.7%

0.7%

Other operating income

163.0

  

  

(59.3)

103.7

-36.4%

-36.4%

Normalized EBIT

647.8

  

  

1.3

649.1

0.2%

0.2%

Normalized EBIT margin

56.3%

  

 

 

53.8%

-250 bps

-250 bps

Normalized EBITDA

706.5

  

  

18.4

724.9

2.6%

2.6%

Normalized EBITDA margin

61.4%

  

 

 

60.1%

-130 bps

-130 bps

 

CSD&Nanc Brazil results

FY13 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

FY14

Reported

Organic

Volume ('000 hl)

30,174.1

  

  

430.9

30,605.0

1.4%

1.4%

Net revenue

3,633.7

  

  

280.5

3,914.2

7.7%

7.7%

Net revenue/hl

120.4

  

  

7.5

127.9

6.2%

6.2%

COGS

(1,588.1)

  

  

(82.7)

(1,670.8)

5.2%

5.2%

COGS/hl

(52.6)

  

  

(2.0)

(54.6)

3.7%

3.7%

Gross profit

2,045.6

  

  

197.8

2,243.4

9.7%

9.7%

Gross margin

56.3%

  

 

 

57.3%

100 bps

100 bps

SG&A excl. deprec.&amort.

(685.0)

  

  

(18.1)

(703.2)

2.6%

2.6%

SG&A deprec.&amort.

(112.0)

  

  

(19.0)

(131.0)

16.9%

16.9%

SG&A total

(797.1)

  

  

(37.1)

(834.2)

4.7%

4.7%

Other operating income

365.6

  

  

(71.2)

294.4

-19.5%

-19.5%

Normalized EBIT

1,614.1

  

  

89.5

1,703.6

5.5%

5.5%

Normalized EBIT margin

44.4%

  

 

 

43.5%

-90 bps

-90 bps

Normalized EBITDA

1,852.9

  

   

127.6

1,980.5

6.9%

6.9%

Normalized EBITDA margin

51.0%

  

 

 

50.6%

-40 bps

-40 bps

 

 

 


 

Fourth Quarter and Full Year 2014 Results

February 26, 2015

Page 13

 

 
HILA-Ex 

 

Our operations in the Central America and the Caribbean (“HILA-Ex”) delivered an EBITDA of R$ 269.3 million (+26.8%) with an EBITDA margin of 38.4% (+290 bps). In the full year, EBITDA totaled R$ 697.7 million (+23.1%) and EBITDA margin expanded to 33.4% (+240 bps).

We had another quarter of double-digits net revenues growth in the region (+17.5%), leading to a 14.5% growth in FY 2014. Top line expansion during the last quarter of the year was mainly driven by volume, which grew across all countries in the region, as we were able to further expand our participation in the alcoholic beverage segment in the Dominican Republic and gained market share in Guatemala, as our commercial strategy remained as a key priority in the country. While still investing behind our brands in the region, we managed to increase our EBITDA in a solid way, sustaining the trend of margin expansion.

 

HILA-Ex results

4Q13 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

4Q14

Reported

Organic

Volume total ('000 hl)

2,102.3

17.5

  

252.2

2,372.0

12.8%

11.9%

Beer volume ('000 hl)

1,704.7

17.5

  

188.2

1,910.4

12.1%

10.9%

CSD volume ('000 hl)

397.6

 

   

64.0

461.5

16.1%

16.1%

Net revenue

552.7

0.3

51.4

96.6

701.0

26.8%

17.5%

Net revenue/hl

262.9

(2.0)

21.7

13.0

295.5

12.4%

5.0%

COGS

(236.2)

(0.1)

(25.3)

(51.9)

(313.5)

32.7%

22.0%

COGS/hl

(112.4)

0.9

(10.6)

(10.0)

(132.2)

17.6%

9.0%

Gross profit

316.5

0.2

26.2

44.7

387.5

22.4%

14.1%

Gross margin

57.3%

 

 

 

55.3%

-200 bps

-170 bps

SG&A excl. deprec.&amort.

(143.3)

(0.0)

(13.0)

(7.0)

(163.3)

13.9%

4.9%

SG&A deprec.&amort.

(12.1)

 

(0.8)

2.1

(10.8)

-11.2%

-17.5%

SG&A total

(155.4)

(0.0)

(13.8)

(4.8)

(174.0)

12.0%

3.1%

Other operating income/expenses

(3.7)

 

(0.1)

5.4

1.6

-141.8%

-145.1%

Normalized EBIT

157.4

0.2

12.3

45.2

215.0

36.6%

28.7%

Normalized EBIT margin

28.5%

 

 

 

30.7%

220 bps

270 bps

Normalized EBITDA

199.4

0.2

16.3

53.5

269.3

35.1%

26.8%

Normalized EBITDA margin

36.1%

 

 

 

38.4%

230 bps

290 bps

 

HILA-Ex results

FY13 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

FY14

Reported

Organic

Volume total ('000 hl)

7,267.4

38.8

  

603.2

7,909.4

8.8%

8.3%

Beer volume ('000 hl)

5,908.3

38.8

 

299.7

6,246.8

5.7%

5.0%

CSD volume ('000 hl)

1,359.1

 

 

303.5

1,662.6

22.3%

22.3%

Net revenue

1,726.6

0.3

111.4

249.6

2,087.8

20.9%

14.5%

Net revenue/hl

237.6

(1.2)

14.1

13.5

264.0

11.1%

5.7%

COGS

(815.5)

(0.1)

(56.5)

(102.2)

(974.3)

19.5%

12.5%

COGS/hl

(112.2)

0.6

(7.1)

(4.4)

(123.2)

9.8%

3.9%

Gross profit

911.1

0.2

54.9

147.4

1,113.5

22.2%

16.2%

Gross margin

52.8%

 

 

 

53.3%

60 bps

80 bps

SG&A excl. deprec.&amort.

(473.2)

(0.0)

(31.2)

(57.2)

(561.7)

18.7%

12.1%

SG&A deprec.&amort.

(47.0)

 

(1.7)

13.5

(35.3)

-25.0%

-28.7%

SG&A total

(520.3)

(0.0)

(33.0)

(43.7)

(596.9)

14.7%

8.4%

Other operating income/expenses

(7.4)

 

(0.6)

5.0

(3.0)

-59.6%

-68.3%

Normalized EBIT

383.5

0.2

21.3

108.7

513.6

33.9%

28.3%

Normalized EBIT margin

22.2%

 

 

 

24.6%

240 bps

270 bps

Normalized EBITDA

542.1

0.2

30.4

125.1

697.7

28.7%

23.1%

Normalized EBITDA margin

31.4%

 

 

 

33.4%

200 bps

240 bps

 

      

 

 


 

Fourth Quarter and Full Year 2014 Results

February 26, 2015

Page 14

 

Latin America South (LAS) 

 

LAS EBITDA expanded 14.6% in the 4Q14 to R$ 1,234.3 million, with an EBITDA margin of 50.8% (-190 bps). For the full year, our EBITDA increased 17.5% to R$ 3,098.7 million and margin contracted 20 bps to 44.5%.

Top line for LAS increased 18.7% during the quarter, as NR/hl grew +22.3%, partially offset by volumes decline of -2.9%. In the full year, volumes were slightly negative (-0.2%), however net revenues per hectoliter grew 18.2%, resulting in a NR growth of 17.9%.

COGS/hl for LAS grew 39.2%, mainly driven by higher inflation and more unfavorable currency hedges in Argentina, lower dilution of fixed costs due to volume decline, along with an extraordinary negative impact from certain raw materials. In the full year, our COGS/hl grew 18.7%.

SG&A (excluding depreciation and amortization) increased by 18.7%, whereas in the full year, it grew 18.6%.

 

LAS results

4Q13 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

4Q14

Reported

Organic

Volume ('000 hl)

11,377.6

  

  

(330.7)

11,047.0

-2.9%

-2.9%

Net revenue

2,341.8

  

(348.7)

438.9

2,432.0

3.9%

18.7%

Net revenue/hl

205.8

  

(31.6)

45.9

220.1

7.0%

22.3%

COGS

(727.7)

  

118.6

(255.8)

(864.9)

18.9%

35.2%

COGS/hl

(64.0)

  

10.7

(25.1)

(78.3)

22.4%

39.2%

Gross profit

1,614.1

 

(230.1)

183.1

1,567.0

-2.9%

11.3%

Gross margin

68.9%

 

 

 

64.4%

-450 bps

-430 bps

SG&A excl. deprec.&amort.

(451.7)

  

86.2

(84.6)

(450.1)

-0.4%

18.7%

SG&A deprec.&amort.

(21.6)

  

9.4

(35.5)

(47.6)

120.9%

164.7%

SG&A total

(473.3)

  

95.7

(120.2)

(497.8)

5.2%

25.4%

Other operating income/expenses

8.3

  

(29.5)

60.5

39.3

nm

nm

Normalized EBIT

1,149.1

  

(163.9)

123.4

1,108.6

-3.5%

10.7%

Normalized EBIT margin

49.1%

 

 

 

45.6%

-350 bps

-330 bps

Normalized EBITDA

1,234.1

  

(179.6)

179.8

1,234.3

0.0%

14.6%

Normalized EBITDA margin

52.7%

 

 

 

50.8%

-190 bps

-190 bps

 

LAS results

FY13 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

FY14

Reported

Organic

Volume ('000 hl)

36,917.7

  

  

(91.3)

36,826.4

-0.2%

-0.2%

Net revenue

7,051.7

  

(1,359.2)

1,263.2

6,955.7

-1.4%

17.9%

Net revenue/hl

191.0

  

(36.9)

34.8

188.9

-1.1%

18.2%

COGS

(2,605.0)

 

477.7

(480.0)

(2,607.3)

0.1%

18.4%

COGS/hl

(70.6)

  

13.0

(13.2)

(70.8)

0.3%

18.7%

Gross profit

4,446.7

  

(881.5)

783.2

4,348.4

-2.2%

17.6%

Gross margin

63.1%

 

 

 

62.5%

-50 bps

-20 bps

SG&A excl. deprec.&amort.

(1,568.4)

  

322.6

(291.3)

(1,537.1)

-2.0%

18.6%

SG&A deprec.&amort.

(103.2)

  

33.0

(69.0)

(139.3)

35.0%

66.9%

SG&A total

(1,671.6)

  

355.6

(360.4)

(1,676.4)

0.3%

21.6%

Other operating income/expenses

(12.3)

  

(5.3)

29.2

11.6

-194.6%

nm

Normalized EBIT

2,762.8

  

(531.3)

452.0

2,683.6

-2.9%

16.4%

Normalized EBIT margin

39.2%

 

 

 

38.6%

-60 bps

-50 bps

Normalized EBITDA

3,150.4

  

(602.9)

551.1

3,098.7

-1.6%

17.5%

Normalized EBITDA margin

44.7%

 

 

 

44.5%

-10 bps

-20 bps

 

 

 


 

Fourth Quarter and Full Year 2014 Results

February 26, 2015

Page 15

 

LAS Beer 

 

During 4Q14, LAS Beer delivered R$ 1,179.3 million (+28.3%) of EBITDA, with an EBITDA margin of 61.9%. In the full year, EBITDA increased 22.0% and EBITDA margin expanded 70 bps up to 54.3%.

In the fourth quarter, volumes declined 2.7%, driven by beer industry contraction, mainly in Argentina, due to the challenging macroeconomic scenario that persists in the country. Along with that, a very poor weather was also a headwind for the industry in the last months. Despite adverse conditions during the year, we were able to protect our volume performance in the region in 2014 (flat year over year), whilst rising our top line in a solid way (FY 2014 +20.5%) by successfully implementing our revenue management initiatives.

COGS/hl increased 39.8% in the quarter, while for the full year, it was up 22.2%. Besides, cash SG&A grew 15.3% in the FY2014.

 

LAS Beer

4Q13 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

4Q14

Reported

Organic

Volume ('000 hl)

7,074.2

  

  

(189.2)

6,885.0

-2.7%

-2.7%

Net revenue

1,759.3

  

(247.3)

391.9

1,903.9

8.2%

22.3%

Net revenue/hl

248.7

  

(35.9)

63.8

276.5

11.2%

25.6%

COGS

(449.1)

  

67.0

(162.1)

(544.3)

21.2%

36.1%

COGS/hl

(63.5)

  

9.7

(25.3)

(79.0)

24.5%

39.8%

Gross profit

1,310.2

  

(180.3)

229.8

1,359.6

3.8%

17.5%

Gross margin

74.5%

 

 

 

71.4%

-310 bps

-290 bps

SG&A excl. deprec.&amort.

(322.5)

  

47.9

(0.9)

(275.5)

-14.6%

0.3%

SG&A deprec.&amort.

(11.9)

  

9.4

(36.4)

(38.8)

nm

nm

SG&A total

(334.4)

  

57.4

(37.3)

(314.3)

-6.0%

11.2%

Other operating income/expenses

3.7

  

(24.0)

47.4

27.1

nm

nm

Normalized EBIT

979.5

  

(147.0)

239.9

1,072.4

9.5%

24.5%

Normalized EBIT margin

55.7%

 

 

 

56.3%

70 bps

100 bps

Normalized EBITDA

1,045.5

  

(162.6)

296.3

1,179.3

12.8%

28.3%

Normalized EBITDA margin

59.4%

 

 

 

61.9%

250 bps

300 bps

 

LAS Beer

FY13 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

FY14

Reported

Organic

Volume ('000 hl)

22,093.0

  

  

2.8

22,095.8

0.0%

0.0%

Net revenue

5,152.0

  

(915.4)

1,058.4

5,294.9

2.8%

20.5%

Net revenue/hl

233.2

  

(41.4)

47.9

239.6

2.8%

20.5%

COGS

(1,530.7)

  

242.4

(340.1)

(1,628.4)

6.4%

22.2%

COGS/hl

(69.3)

  

11.0

(15.4)

(73.7)

6.4%

22.2%

Gross profit

3,621.3

  

(673.0)

718.3

3,666.6

1.3%

19.8%

Gross margin

70.3%

 

 

 

69.2%

-100 bps

-40 bps

SG&A excl. deprec.&amort.

(1,074.3)

  

197.8

(164.0)

(1,040.5)

-3.1%

15.3%

SG&A deprec.&amort.

(64.4)

  

29.9

(70.3)

(104.8)

62.7%

109.1%

SG&A total

(1,138.7)

  

227.7

(234.3)

(1,145.3)

0.6%

20.6%

Other operating income/expenses

(10.2)

  

(3.3)

21.3

7.9

-177.1%

nm

Normalized EBIT

2,472.4

  

(448.6)

505.3

2,529.1

2.3%

20.4%

Normalized EBIT margin

48.0%

 

 

 

47.8%

-20 bps

-10 bps

Normalized EBITDA

2,777.3

  

(514.7)

611.2

2,873.8

3.5%

22.0%

Normalized EBITDA margin

53.9%

 

 

 

54.3%

40 bps

70 bps

 

 

 

 


 

Fourth Quarter and Full Year 2014 Results

February 26, 2015

Page 16

 

LAS CSD & NANC 

 

In LAS CSD & NANC, our EBITDA declined by 61.8% to R$ 55.0 million in the quarter and -16.1% in FY 2014 (R$ 224.9 million).

CSD & NANC volumes decreased 3.3% in 4Q14, mainly driven by industry contraction in Argentina, once the consumer environment remains weak in the country. Despite this scenario, our volumes were only slightly negative in the full year (-0.6%). During 2014, our NR/hl grew 11.5% (+11.7% in the last quarter), resulting in a top line growth of 10.8%, as we also implemented our revenue management initiatives in CSD & NANC segment along the year.

LAS CSD & NANC COGS/hl grew 38.2% in 4Q14 (FY2014, +13.8%). Mainly affected by the tough macroeconomic conditions arising from Argentina, SG&A (excluding depreciation and amortization) increased 25.8% in the full year, as inflationary pressures, adversely impacted labor-related expenses.

 

LAS CSD&Nanc

4Q13 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

4Q14

Reported

Organic

Volume ('000 hl)

4,303.4

  

  

(141.5)

4,161.9

-3.3%

-3.3%

Net revenue

582.5

  

(101.4)

47.0

528.1

-9.3%

8.1%

Net revenue/hl

135.4

  

(24.4)

15.9

126.9

-6.3%

11.7%

COGS

(278.6)

  

51.6

(93.7)

(320.7)

15.1%

33.6%

COGS/hl

(64.7)

  

12.4

(24.7)

(77.1)

19.0%

38.2%

Gross profit

303.9

  

(49.8)

(46.7)

207.4

-31.8%

-15.4%

Gross margin

52.2%

 

 

 

39.3%

-1290 bps

-1130 bps

SG&A excl. deprec.&amort.

(129.2)

  

38.3

(83.7)

(174.6)

35.2%

64.8%

SG&A deprec.&amort.

(9.7)

  

(0.0)

0.9

(8.8)

-9.1%

-9.1%

SG&A total

(138.9)

  

38.3

(82.9)

(183.4)

32.1%

59.7%

Other operating income/expenses

4.6

  

(5.5)

13.1

12.2

167.4%

nm

Normalized EBIT

169.6

  

(16.9)

(116.5)

36.2

-78.7%

-68.7%

Normalized EBIT margin

29.1%

 

 

 

6.9%

-2230 bps

-2070 bps

Normalized EBITDA

188.5

  

(17.1)

(116.5)

55.0

-70.8%

-61.8%

Normalized EBITDA margin

32.4%

 

 

 

10.4%

-2200 bps

-2090 bps

 

LAS CSD&Nanc

FY13 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

FY14

Reported

Organic

Volume ('000 hl)

14,824.7

  

  

(94.0)

14,730.6

-0.6%

-0.6%

Net revenue

1,899.7

  

(443.7)

204.8

1,660.7

-12.6%

10.8%

Net revenue/hl

128.1

  

(30.1)

14.7

112.7

-12.0%

11.5%

COGS

(1,074.3)

  

235.3

(140.0)

(979.0)

-8.9%

13.0%

COGS/hl

(72.5)

  

16.0

(10.0)

(66.5)

-8.3%

13.8%

Gross profit

825.4

  

(208.5)

64.9

681.8

-17.4%

7.9%

Gross margin

43.4%

 

 

 

41.1%

-240 bps

-110 bps

SG&A excl. deprec.&amort.

(494.2)

  

124.8

(127.3)

(496.6)

0.5%

25.8%

SG&A deprec.&amort.

(38.8)

  

3.0

1.3

(34.5)

-11.1%

-3.3%

SG&A total

(532.9)

  

127.9

(126.0)

(531.1)

-0.3%

23.7%

Other operating income/expenses

(2.1)

  

(2.0)

7.9

3.8

nm

nm

Normalized EBIT

290.4

  

(82.7)

(53.3)

154.5

-46.8%

-18.3%

Normalized EBIT margin

15.3%

 

 

 

9.3%

-600 bps

-400 bps

Normalized EBITDA

373.1

  

(88.1)

(60.1)

224.9

-39.7%

-16.1%

Normalized EBITDA margin

19.6%

 

 

 

13.5%

-610 bps

-470 bps

 

 

 


 

Fourth Quarter and Full Year 2014 Results

February 26, 2015

Page 17

 

Canada 

 

Our Canadian operations delivered R$ 483.7 million of EBITDA (+3.1%), while our EBITDA margin increased 80 bps to 40.6%. For the full year, EBITDA reached R$ 1,754.5 million (-0.7%) and EBITDA margin was 37.7% (-20 bps).

The beer industry in Canada expanded during the last quarter of the year, mostly driven by warmer temperatures than last year. Although our volume growth in the quarter was slightly positive on an organic basis (+0.3%), our reported volumes grew 4.6%, impacted by the addition to our portfolio of Corona and other brands from Grupo Modelo since the beginning of last March, achieving 41.7% of market share.

During the 4Q14, our net revenues per hectoliter increased 0.7% as a result of our revenue management initiatives and continuously focus on the premium segment and innovation pipeline, delivering strong results with brands like Shock Top, which has been one of the fastest-growing brands in Canada during the year. We also took the chance to leverage once again our cost efficiency strengths to improve both COGS and SG&A, further accelerating EBITDA growth in the last quarter of the year.

The scope change in Canada refers to the addition of the Grupo Modelo brands commencing on March 1st as well as a change in accounting methodology for our joint venture distribution companies from proportionate consolidation to equity accounting.

 

Canada results

4Q13 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

4Q14

Reported

Organic

Volume ('000 hl)

2,180.8

91.4

  

7.9

2,280.0

4.6%

0.3%

Net revenue

1,076.1

69.3

34.4

11.9

1,191.7

10.7%

1.0%

Net revenue/hl

493.4

10.7

15.1

3.5

522.7

5.9%

0.7%

COGS

(318.3)

(29.3)

(10.0)

6.1

(351.4)

10.4%

-1.8%

COGS/hl

(146.0)

(7.0)

(4.4)

3.2

(154.1)

5.6%

-2.1%

Gross profit

757.8

40.1

24.4

18.0

840.3

10.9%

2.3%

Gross margin

70.4%

 

 

 

70.5%

10 bps

80 bps

SG&A excl. deprec.&amort.

(328.1)

(52.7)

(11.0)

5.1

(386.8)

17.9%

-1.3%

SG&A deprec.&amort.

(17.6)

5.2

(0.3)

1.4

(11.3)

-36.1%

-11.7%

SG&A total

(345.7)

(47.5)

(11.3)

6.5

(398.0)

15.1%

-1.7%

Other operating income/expenses

0.6

(5.8)

0.1

2.0

(3.1)

nm

-38.2%

Normalized EBIT

412.6

(13.3)

13.2

26.5

439.1

6.4%

6.6%

Normalized EBIT margin

38.3%

 

 

 

36.8%

-150 bps

190 bps

Normalized EBITDA

473.5

(18.5)

14.5

14.2

483.7

2.2%

3.1%

Normalized EBITDA margin

44.0%

 

 

 

40.6%

-340 bps

80 bps

 

Canada results

FY13 Reference Base

 

Currency Translation

Organic Growth

 

% As

%

R$ million

Scope

FY14

Reported

Organic

Volume ('000 hl)

9,135.2

453.2

  

(67.4)

9,520.9

4.2%

-0.7%

Net revenue

4,260.1

313.7

86.6

(6.9)

4,653.4

9.2%

-0.2%

Net revenue/hl

466.3

10.7

9.1

2.7

488.8

4.8%

0.6%

COGS

(1,240.3)

(126.3)

(25.4)

(7.8)

(1,399.8)

12.9%

0.6%

COGS/hl

(135.8)

(6.8)

(2.7)

(1.8)

(147.0)

8.3%

1.3%

Gross profit

3,019.8

187.4

61.2

(14.7)

3,253.7

7.7%

-0.5%

Gross margin

70.9%

 

 

 

69.9%

-100 bps

-20 bps

SG&A excl. deprec.&amort.

(1,356.1)

(220.1)

(29.0)

(6.7)

(1,611.9)

18.9%

0.4%

SG&A deprec.&amort.

(54.9)

21.3

(0.7)

(3.3)

(37.6)

-31.5%

9.8%

SG&A total

(1,411.0)

(198.8)

(29.7)

(10.0)

(1,649.5)

16.9%

0.6%

Other operating income/expenses

5.9

(25.0)

0.4

15.2

(3.4)

-157.3%

-79.9%

Normalized EBIT

1,614.8

(36.4)

31.9

(9.5)

1,600.8

-0.9%

-0.6%

Normalized EBIT margin

37.9%

 

 

 

34.4%

-350 bps

-10 bps

Normalized EBITDA

1,789.9

(57.7)

35.0

(12.7)

1,754.5

-2.0%

-0.7%

Normalized EBITDA margin

42.0%

 

 

 

37.7%

-430 bps

-20 bps

 

 


 

Fourth Quarter and Full Year 2014 Results

February 26, 2015

Page 18

 

Other operating income/(expense) 

 

Other operating income/(expense) declined R$ 79.9 million, totaling R$ 663.1 million in 4Q14. As previously mentioned, in the fourth quarter of 2013, we recorded a one-time gain of R$ 300 million related to a recovery of restricted funds. This hard comparable base was partially offset by a solid growth of our government grants related to state VAT long-term tax incentives. In the FY 2014, other operating income/(expense) achieved R$ 1,629.2 million.

 

Other operating income/(expenses)

4Q13
Reference
Base

4Q14

FY13 Reference Base

FY14

 

   

 

 

R$ million

   

 

 

 

   

 

 

Government grants/NPV of long term fiscal incentives

343.2

530.4

1,148.0

1,479.9

(Additions to)/reversals of provisions

(53.0)

(35.9)

(69.9)

(32.2)

Net gain on disposal of property, plant and equipment and intangible assets

7.3

38.8

24.7

33.9

Net other operating income

445.5

129.8

658.9

147.6

 

   

 

 

 

743.0

663.1

1,761.7

1,629.2

 

 

Exceptional items 

 

During the fourth quarter we recorded an expense of R$ 63.2 million in exceptional items (as compared to R$ 16.0 million in 4Q13).

 

Exceptional items

4Q13
Reference
Base

4Q14

FY13 Reference Base

FY14

 

   

 

 

R$ million

   

 

 

 

   

 

 

Restructuring

(16.0)

(23.1)

(29.2)

(48.9)

Impairment of fixed assets

 

(32.3)

  

(32.3)

Other exceptional items

     

(7.8)

 

(7.8)

 

 

 

 

 

 

(16.0)

(63.2)

(29.2)

(89.0)

 


 

Fourth Quarter and Full Year 2014 Results

February 26, 2015

Page 19

 

Net finance results 

 

Net finance results totaled an expense of R$ 587.5 million during the fourth quarter, which was R$ 28.6 million worse than 4Q13. In addition to the non-cash interest expense of approximately R$ 90 million in connection with the put option associated with our investment in the Dominican Republic,  we had a one time non cash expense of R$ 178 million related to the fair value adjustment of such option. Our performance was also impacted by higher expenses with derivative instruments.

 

 

Net finance results

4Q13
Reference
Base

4Q14

FY13 Reference Base

FY14

 

 

     

 

 

 

 

 

R$ million

 

 

 

 

 

 

     

 

 

 

 

 

 

Interest income

128.8

109.4

343.4

399.4

 

 

 

Interest expenses

(146.9)

(195.3)

(533.0)

(697.4)

 

 

 

Gains/(losses) on derivative instruments

2.0

(78.8)

(201.0)

(244.9)

 

 

 

Gains/(losses) on non-derivative instruments

(239.9)

(209.4)

(512.1)

(435.8)

 

 

 

Taxes on financial transactions

(20.9)

(20.7)

(86.4)

(78.1)

 

 

 

Other financial income/(expenses), net

(282.0)

(192.7)

(572.4)

(418.6)

 

 

       

 

 

 

 

Net finance results

(558.9)

(587.5)

(1,561.4)

(1,475.4)

 

 

As of December 31, 2014 we held a net cash position of R$ 7,713.3 million (down from R$ 8,921.0 million as of December 31, 2013).  Consolidated debt corresponded to R$ 2,622.6 million whereas cash and cash equivalents less bank overdrafts totaled R$ 9,623.0 million, down from R$ 11,538.2 million as of December 31, 2013.

 

 

 

 

December 2013

December 2014

 

Debt Breakdown

Current

Non-current

Total

Current

Non-current

Total

 

       

 

 

 

 

Local Currency

574.9

1,361.8

1,936.7

572.3

1,422.5

1,994.8

 

Foreign Currency

465.7

503.5

969.1

415.8

212.1

627.9

 

Consolidated Debt

1,040.6

1,865.2

2,905.8

988.1

1,634.6

2,622.6

 

       

 

 

 

 

Cash and Cash Equivalents less Bank Overdrafts

11,538.2

 

 

9,623.0

 

Current Investment Securities

   

288.6

 

 

713.0

 

       

 

 

 

 

Net Debt/ (Cash)

   

(8,921.0)

 

 

(7,713.3)

 

 

 

 

 

 

 

 

 

 


 

Fourth Quarter and Full Year 2014 Results

February 26, 2015

Page 20

 

 

Provision for income tax & social contribution 

 

The weighted nominal tax rate for the quarter was 32.1%, compared to 33.1% of 4Q13, while the effective tax rate was up from 11.5% to 14.9%. In the full year, our effective tax rate was 14.0% given higher interest on capital benefit during the year.

The table below shows the reconciliation for income tax and social contribution provision.

 

 

 

 

4Q13
Reference
Base

 

FY13 Reference Base

 

 

 

Income tax and social contribution

 

 

 

 

R$ million

4Q14

YTD14

 

 

 

 

 

 

 

 

 

 

Profit before tax

5,382.6

5,476.0

13,880.8

14,368.6

 

 

     

 

 

 

 

 

Adjustment on taxable basis

 

 

 

 

 

 

 

Non-taxable net financial and other income

(392.2)

(299.4)

(631.6)

(550.0)

 

 

 

Goverment grants (VAT)

(262.5)

(430.2)

(794.1)

(1,196.8)

 

 

 

Share of results of associates

(5.7)

(4.2)

(11.4)

(17.4)

 

 

 

Expenses not deductible for tax purposes

302.8

393.9

375.5

507.6

 

 

   

5,024.9

5,136.2

12,819.2

13,112.0

 

 

 

Aggregated weighted nominal tax rate

33.1%

32.1%

32.9%

32.0%

 

 

 

Taxes – nominal rate

(1,665.1)

(1,649.7)

(4,211.9)

(4,200.9)

 

 

     

 

 

 

 

 

Adjustment on tax expense

 

 

 

 

 

 

 

Tax benefit - interest on shareholders' equity

732.0

709.8

860.6

1,729.8

 

 

 

Tax benefit - amortization on tax books

96.0

40.6

283.8

202.3

 

 

 

Other tax adjustments

219.6

82.3

586.2

262.2

 

 

 

Income tax and social contribution expense

(617.6)

(816.9)

(2,481.4)

(2,006.6)

 

 

 

Effective tax rate

11.5%

14.9%

17.9%

14.0%

 

 

 

 

 

 

 

 

 

 

Shareholding structure 

 

The table below summarizes Ambev S.A.’s shareholding structure as of December 31, 2014.

 

Ambev S.A.'s shareholding structure

 

 

ON

%Outs

Anheuser-Busch InBev

9,716,577,918

61.8%

FAHZ

1,542,600,201

9.8%

Market

4,453,023,716

28.3%

Outstanding

15,712,201,835

100.0%

Treasury

417,420

 

TOTAL

15,712,619,255

 

Free float BM&FBovespa

3,105,456,570

19.8%

Free float NYSE

1,347,567,146

8.6%

 

 

 


 

Fourth Quarter and Full Year 2014 Results

February 26, 2015

Page 21

 

Reconciliation between normalized EBITDA & profit 

 

Both Normalized EBITDA and EBIT are measures used by Ambev’s management to measure the Company’s performance. 

Normalized EBITDA is calculated excluding from Profit the following effects: (i) Non-controlling interest, (ii) Income Tax expense, (iii) Share of results of associates, (iv) Net finance results, (v) Special items, and (vi) Depreciation & Amortization.  

Normalized EBITDA and EBIT are not accounting measures under accounting practices in Brazil, IFRS or the United States of America (US GAAP) and should not be considered as an alternative to Profit as a measure of operational performance or an alternative to Cash Flow as a measure of liquidity.  Normalized EBITDA and EBIT do not have a standard calculation method and Ambev’s definition of Normalized EBITDA and EBIT may not be comparable to that of other companies.

 

 

Reconciliation - Profit to EBITDA

4Q13
Reference
Base

4Q14

FY13 Reference Base

FY14

 

Profit - Ambev holders

4,673.7

4,538.4

9,557.3

12,065.5

 

Non-controlling interest

91.2

120.7

1,842.1

296.5

 

Income tax expense

617.6

816.9

2,481.4

2,006.6

 

Profit before taxes

5,382.6

5,476.0

13,880.8

14,368.6

 

Share of results of associates

(5.7)

(4.2)

(11.4)

(17.4)

 

Net finance results

558.9

587.5

1,561.4

1,475.4

 

Exceptional items

16.0

63.2

29.2

89.0

 

Normalized EBIT

5,951.7

6,122.5

15,460.0

15,915.6

 

Depreciation & amortization - total

522.9

678.6

2,105.1

2,360.2

 

Normalized EBITDA

6,474.6

6,801.1

17,565.1

18,275.8

 

            

 
2013 Reference Base 

 

In view of the stock swap merger involving Companhia de Bebidas das Américas – Ambev and Ambev S.A., which was approved by shareholders on July 30, 2013, the 2013 Reference Base figures reflect the predecessor cost accounting method applied to 2013 figures previously reported for comparability purposes, since the stock swap merger involved entities under common control.

In addition, as from January 1, 2014 our HILA-Ex region also includes the operations of Bucanero. To that effect, we have in this release restated figures for 2013, once the predecessor cost accounting method was also applied to this transaction that involved entities under common control.

 

 


 

Fourth Quarter and Full Year 2014 Results

February 26, 2015

Page 22

 

Q4 2014 Earnings Conference Call 
 

Speakers:

Bernardo Paiva

Chief Executive Officer

 

Nelson Jamel

Chief Financial and Investor Relations Officer

 

 

 

Language:

English

 

 

 

 

Date:

February 26, 2015 (Thursday)

 

 

 

 

Time:

12:00 (Brasília time)

10:00 (EST)

 

 

 

 

Phone number:

US participants

+ 1 (877) 317-6776

 

International participants

+ 1 (412) 317-6776

 

 

 

Conference ID:

Ambev

 

 

Please call 15 minutes prior to the beginning of the conference call.

Webcast: The conference call will also be transmitted live through the Internet, available on Ambev’s website:

http://webcast.neo1.net/Cover.aspx?PlatformId=B7CXIKp%2FLpPKh43wtWDXvw%3D%3D

Playback: The conference call replay through internet will be available one hour after conclusion at Ambev’s website at the same link above. For Playback through telephone: participants calling from USA: +1 (877) 344-7529 / participants calling from other countries: +1 (412) 317-0088 / Code: 10059425 - enter "1" to start the playback.

 

For additional information, please contact the Investor Relations team:

 

Marino Lima

(+55 11) 2122-1415
marino.lima@ambev.com.br

 

 Fernando Robbi
(+55 11) 2122-1414
fernando.robbi@ambev.com.br

 

www.ambev-ir.com

 

 

 

Statements contained in this press release may contain information that is forward-looking and reflects management’s current view and estimates of future economic circumstances, industry conditions, company performance, and finance results. Any statements, expectations, capabilities, plans and assumptions contained in this press release that do not describe historical facts, such as statements regarding the declaration or payment of dividends, the direction of future operations, the implementation of principal operating and financing strategies and capital expenditure plans, the factors or trends affecting financial condition, liquidity or results of operations, are forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and involve a number of risks and uncertainties. There is no guarantee that these results will actually occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors could cause actual results to differ materially from current expectations.

 

 

 

 


 

Fourth Quarter and Full Year 2014 Results

February 26, 2015

Page 23

 

 

Ambev - Segment financial information

 

 

 

 

 

 

 

 

 

Organic results

 

 

 

 

 

 

 

 

 

 

Ambev Brazil

 

Beer Brazil

CSD & NANC Brazil

Total Ambev Brazil

 

4Q13 Reference Base

4Q14

%

4Q13 Reference Base

4Q14

%

4Q13 Reference Base

4Q14

%

Volumes (000 hl)

24,646

25,009

1.5%

9,020

8,864

-1.7%

33,666

33,873

0.6%

 

   

 

 

 

 

 

 

 

R$ million

 

 

 

 

 

 

 

 

 

Net sales

6,011.7

6,701.1

11.5%

1,150.3

1,207.1

4.9%

7,162.0

7,908.2

10.4%

% of total

54.0%

54.8%

 

10.3%

9.9%

 

64.3%

64.6%

 

COGS

(1,585.9)

(1,829.7)

15.4%

(455.5)

(450.3)

-1.1%

(2,041.4)

(2,280.0)

11.7%

% of total

47.7%

48.0%

 

13.7%

11.8%

 

61.4%

59.8%

 

Gross profit

4,425.8

4,871.4

10.1%

694.8

756.8

8.9%

5,120.6

5,628.2

9.9%

% of total

56.7%

57.8%

 

8.9%

9.0%

 

65.6%

66.8%

 

SG&A

(1,415.8)

(1,682.4)

18.8%

(210.1)

(211.5)

0.7%

(1,625.9)

(1,893.9)

16.5%

% of total

54.4%

56.8%

 

8.1%

7.1%

 

62.5%

63.9%

 

Other operating income/(expenses)

574.8

521.7

-9.2%

163.0

103.7

-36.4%

737.9

625.4

-15.2%

% of total

77.4%

78.7%

 

21.9%

15.6%

 

99.3%

94.3%

 

Normalized EBIT

3,584.8

3,710.7

3.5%

647.8

649.1

0.2%

4,232.6

4,359.8

3.0%

% of total

60.2%

60.6%

 

10.9%

10.6%

 

71.1%

71.2%

 

Normalized EBITDA

3,861.1

4,088.9

5.9%

706.5

724.9

2.6%

4,567.6

4,813.9

5.4%

% of total

59.6%

60.1%

 

10.9%

10.7%

 

70.5%

70.8%

 

 

   

 

 

 

 

   

 

% of net sales

 

 

 

 

 

 

 

 

 

Net sales

100.0%

100.0%

 

100.0%

100.0%

 

100.0%

100.0%

 

COGS

-26.4%

-27.3%

 

-39.6%

-37.3%

 

-28.5%

-28.8%

 

Gross profit

73.6%

72.7%

 

60.4%

62.7%

 

71.5%

71.2%

 

SG&A

-23.6%

-25.1%

 

-18.3%

-17.5%

 

-22.7%

-23.9%

 

Other operating income/(expenses)

9.6%

7.8%

 

14.2%

8.6%

 

10.3%

7.9%

 

Normalized EBIT

59.6%

55.4%

 

56.3%

53.8%

 

59.1%

55.1%

 

Normalized EBITDA

64.2%

61.0%

 

61.4%

60.1%

 

63.8%

60.9%

 

 

   

 

 

 

 

   

 

Per hectoliter - (R$/hl)

 

 

 

 

 

 

 

 

 

Net sales

243.9

267.9

9.8%

127.5

136.2

6.8%

212.7

233.5

9.7%

COGS

(64.3)

(73.2)

13.7%

(50.5)

(50.8)

0.6%

(60.6)

(67.3)

11.0%

Gross profit

179.6

194.8

8.5%

77.0

85.4

10.8%

152.1

166.2

9.2%

SG&A

(57.4)

(67.3)

17.1%

(23.3)

(23.9)

2.4%

(48.3)

(55.9)

15.8%

Other operating income/(expenses)

23.3

20.9

-10.6%

18.1

11.7

-35.3%

21.9

18.5

-15.8%

Normalized EBIT

145.5

148.4

2.0%

71.8

73.2

2.0%

125.7

128.7

2.4%

Normalized EBITDA

156.7

163.5

4.4%

78.3

81.8

4.4%

135.7

142.1

4.7%

 

Ambev - Segment financial information

 

 

 

 

 

 

 

 

 

 

 

Organic results

 

 

 

 

 

 

 

 

 

 

 

 

 

Hila Operations

Canada

Ambev

 

LAS

Hila-ex

Operations

Consolidated

 

4Q13 Reference Base

4Q14

%

4Q13 Reference Base

4Q14

%

4Q13 Reference Base

4Q14

%

4Q13 Reference Base

4Q14

%

Volumes (000 hl)

11,378

11,047

-2.9%

2,102

2,372

11.9%

2,181

2,280

0.3%

49,327

49,572

0.3%

 

 

 

 

 

 

 

 

 

 

 

 

 

R$ million

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

2,341.8

2,432.0

18.7%

552.7

701.0

17.5%

1,076.1

1,191.7

1.0%

11,132.6

12,232.9

11.5%

% of total

21.0%

19.9%

 

5.0%

5.7%

 

9.7%

9.7%

 

100.0%

100.0%

 

COGS

(727.7)

(864.9)

35.2%

(236.2)

(313.5)

22.0%

(318.3)

(351.4)

-1.8%

(3,323.6)

(3,809.8)

16.1%

% of total

21.9%

22.7%

 

7.1%

8.2%

 

9.6%

9.2%

 

100.0%

100.0%

 

Gross profit

1,614.1

1,567.0

11.3%

316.5

387.5

14.1%

757.8

840.3

2.3%

7,809.0

8,423.0

9.6%

% of total

20.7%

18.6%

 

4.1%

4.6%

 

9.7%

10.0%

 

100.0%

100.0%

 

SG&A

(473.3)

(497.8)

25.4%

(155.4)

(174.0)

3.1%

(345.7)

(398.0)

-1.7%

(2,600.3)

(2,963.6)

14.6%

% of total

18.2%

16.8%

 

6.0%

5.9%

 

13.3%

13.4%

 

100.0%

100.0%

 

Other operating income/(expenses)

8.3

39.3

nm

(3.7)

1.6

-145.01

0.6

(3.1)

-38.2%

743.0

663.1

-6.0%

% of total

1.1%

5.9%

 

-0.5%

0.2%

 

0.1%

-0.5%

 

100.0%

100.0%

 

Normalized EBIT

1,149.1

1,108.6

10.7%

157.4

215.0

28.7%

412.6

439.1

6.6%

5,951.7

6,122.5

5.4%

% of total

19.3%

18.1%

 

2.6%

3.5%

 

6.9%

7.2%

 

100.0%

100.0%

 

Normalized EBITDA

1,234.1

1,234.3

14.6%

199.4

269.3

26.8%

473.5

483.7

3.1%

6,474.6

6,801.1

7.6%

% of total

19.1%

18.1%

 

3.1%

4.0%

 

7.3%

7.1%

 

100.0%

100.0%

 

 

   

 

 

 

 

 

 

 

 

 

 

% of net sales

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

100.0%

100.0%

 

100.0%

100.0%

 

100.0%

100.0%

 

100.0%

100.0%

 

COGS

-31.1%

-35.6%

 

-42.7%

-44.7%

 

-29.6%

-29.5%

 

-29.9%

-31.1%

 

Gross profit

68.9%

64.4%

 

57.3%

55.3%

 

70.4%

70.5%

 

70.1%

68.9%

 

SG&A

-20.2%

-20.5%

 

-28.1%

-24.8%

 

-32.1%

-33.4%

 

-23.4%

-24.2%

 

Other operating income/(expenses)

0.4%

1.6%

 

-0.7%

0.2%

 

0.1%

-0.3%

 

6.7%

5.4%

 

Normalized EBIT

49.1%

45.6%

 

28.5%

30.7%

 

38.3%

36.8%

 

53.5%

50.0%

 

Normalized EBITDA

52.7%

50.8%

 

36.1%

38.4%

 

44.0%

40.6%

 

58.2%

55.6%

 

 

   

 

 

 

 

 

 

 

 

 

 

Per hectoliter - (R$/hl)

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

205.8

220.1

22.3%

262.9

295.5

5.0%

493.4

522.7

0.7%

225.7

246.8

11.2%

COGS

(64.0)

(78.3)

39.2%

(112.4)

(132.2)

9.0%

(146.0)

(154.1)

-2.1%

(67.4)

(76.9)

15.8%

Gross profit

141.9

141.9

14.7%

150.6

163.4

2.0%

347.5

368.5

1.9%

158.3

169.9

9.3%

SG&A

(41.6)

(45.1)

29.1%

(73.9)

(73.4)

-7.9%

(158.5)

(174.6)

-0.4%

(52.7)

(59.8)

14.3%

Other operating income/(expenses)

0.7

3.6

nm

(1.8)

0.7

-140.3%

0.3

(1.4)

-38.4%

15.1

13.4

-6.3%

Normalized EBIT

101.0

100.4

14.1%

74.9

90.7

15.0%

189.2

192.6

4.6%

120.7

123.5

5.1%

Normalized EBITDA

108.5

111.7

18.0%

94.8

113.5

13.3%

217.1

212.1

0.2%

131.3

137.2

7.4%

 

.


 

Fourth Quarter and Full Year 2014 Results

February 26, 2015

Page 24

 

 

Ambev - Segment financial information

 

 

 

 

 

 

 

 

Organic Results

 

 

 

 

 

 

 

 

 

 

Ambev Brazil

 

Beer Brazil

CSD & NANC Brazil

Total Ambev Brazil

 

FY13 Reference Base

FY14

%

FY13 Reference Base

FY14

%

FY13 Reference Base

FY14

%

Volumes (000 hl)

82,974

86,904

4.7%

30,174

30,605

1.4%

113,148

117,509

3.9%

 

   

 

 

 

 

 

 

 

R$ million

 

 

 

 

 

 

 

 

 

Net sales

18,407.2

20,468.6

11.2%

3,633.7

3,914.2

7.7%

22,040.8

24,382.8

10.6%

% of total

52.5%

53.8%

 

10.4%

10.3%

 

62.8%

64.0%

 

COGS

(5,323.7)

(6,162.4)

15.8%

(1,588.1)

(1,670.8)

5.2%

(6,911.8)

(7,833.2)

13.3%

% of total

46.0%

48.1%

 

13.7%

13.0%

 

59.7%

61.1%

 

Gross profit

13,083.4

14,306.2

9.3%

2,045.6

2,243.4

9.7%

15,129.0

16,549.6

9.4%

% of total

55.7%

56.6%

 

8.7%

8.9%

 

64.4%

65.5%

 

SG&A

(5,408.4)

(6,221.8)

15.0%

(797.1)

(834.2)

4.7%

(6,205.4)

(7,055.9)

13.7%

% of total

55.1%

56.7%

 

8.1%

7.6%

 

63.3%

64.3%

 

Other operating income/(expenses)

1,409.8

1,329.6

-5.7%

365.6

294.4

-19.5%

1,775.4

1,623.9

-8.5%

% of total

80.0%

81.6%

 

20.8%

18.1%

 

100.8%

99.7%

 

Normalized EBIT

9,084.8

9,414.0

3.6%

1,614.1

1,703.6

5.5%

10,699.0

11,117.6

3.9%

% of total

58.8%

59.1%

 

10.4%

10.7%

 

69.2%

69.9%

 

Normalized EBITDA

10,229.8

10,744.4

5.0%

1,852.9

1,980.5

6.9%

12,082.7

12,724.9

5.3%

% of total

58.2%

58.8%

 

10.5%

10.8%

 

68.8%

69.6%

 

 

   

 

 

 

 

   

 

% of net sales

 

 

 

 

 

 

 

 

 

Net sales

100.0%

100.0%

 

100.0%

100.0%

 

100.0%

100.0%

 

COGS

-28.9%

-30.1%

 

-43.7%

-42.7%

 

-31.4%

-32.1%

 

Gross profit

71.1%

69.9%

 

56.3%

57.3%

 

68.6%

67.9%

 

SG&A

-29.4%

-30.4%

 

-21.9%

-21.3%

 

-28.2%

-28.9%

 

Other operating income/(expenses)

7.7%

6.5%

 

10.1%

7.5%

 

8.1%

6.7%

 

Normalized EBIT

49.4%

46.0%

 

44.4%

43.5%

 

48.5%

45.6%

 

Normalized EBITDA

55.6%

52.5%

 

51.0%

50.6%

 

54.8%

52.2%

 

 

   

 

 

 

 

   

 

Per hectoliter - (R$/hl)

 

 

 

 

 

 

 

 

 

Net sales

221.8

235.5

6.2%

120.4

127.9

6.2%

194.8

207.5

6.5%

COGS

(64.2)

(70.9)

10.5%

(52.6)

(54.6)

3.7%

(61.1)

(66.7)

9.1%

Gross profit

157.7

164.6

4.4%

67.8

73.3

8.1%

133.7

140.8

5.3%

SG&A

(65.2)

(71.6)

9.8%

(26.4)

(27.3)

3.2%

(54.8)

(60.0)

9.5%

Other operating income/(expenses)

17.0

15.3

-10.0%

12.1

9.6

-20.6%

15.7

13.8

-11.9%

Normalized EBIT

109.5

108.3

-1.1%

53.5

55.7

4.1%

94.6

94.6

0.1%

Normalized EBITDA

123.3

123.6

0.3%

61.4

64.7

5.4%

106.8

108.3

1.4%

 

Ambev - Segment financial information

 

 

 

 

 

 

 

 

 

 

Organic Results

 

 

 

 

 

 

 

 

 

 

 

 

 

Hila Operations

Canada

Ambev

 

LAS

Hila-ex

Operations

Consolidated

 

FY13 Reference Base

FY14

%

FY13 Reference Base

FY14

%

FY13 Reference Base

FY14

%

FY13 Reference Base

FY14

%

Volumes (000 hl)

36,918

36,826

-0.2%

7,267

7,909

8.3%

9,135

9,521

-0.7%

166,468

171.766

2.9%

 

 

 

 

 

 

 

 

 

 

 

 

 

R$ million

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

7,051.7

6,955.7

17.9%

1,726.6

2,087.8

14.5%

4,260.1

4,653.4

-0.2%

35,079.1

38,079.8

10.9%

% of total

20.1%

18.3%

 

4.9%

5.5%

 

12.1%

12.2%

 

100.0%

100.0%

 

COGS

(2,605.0)

(2,607.3)

18.4%

(815.5)

(974.3)

12.5%

(1,240.3)

(1,399.8)

0.6%

(11,572.5)

(12,814.6)

12.9%

% of total

22.5%

20.3%

 

7.0%

7.6%

 

10.7%

10.9%

 

100.0%

100.0%

 

Gross profit

4,446.7

4,348.4

17.6%

911.1

1,113.5

16.2%

3,019.8

3,253.7

-0.5%

23,506.6

25,265.2

9.9%

% of total

18.9%

17.2%

 

3.9%

4.4%

 

12.8%

12.9%

 

100.0%

100.0%

 

SG&A

(1,671.6)

(1,676.4)

21.6%

(520.3)

(596.9)

8.4%

(1,411.0)

(1,649.5)

0.6%

(9,808.3)

(10,978.7)

12.6%

% of total

17.0%

15.3%

 

5.3%

5.4%

 

14.4%

15.0%

 

100.0%

100.0%

 

Other operating income/(expenses)

(12.3)

11.6

nm

(7.4)

(3.0)

-68.3%

5.9

(3.4)

-79.9%

1,761.7

1,629.2

-5.9%

% of total

-0.7%

0.7%

 

-0.4%

-0.2%

 

0.3%

-0.2%

 

100.0%

100.0%

 

Normalized EBIT

2,762.8

2,683.6

16.4%

383.5

513.6

28.3%

1,614.8

1,600.8

-0.6%

15,460.0

15,915.6

6.3%

% of total

17.9%

16.9%

 

2.5%

3.2%

 

10.4%

10.1%

 

100.0%

100.0%

 

Normalized EBITDA

3,150.4

3,098.7

17.5%

542.1

697.7

23.1%

1,789.9

1,754.5

-0.7%

17,565.1

18,275.8

7.5%

% of total

17.9%

17.0%

 

3.1%

3.8%

 

10.2%

9.6%

 

100.0%

100.0%

 

 

   

 

 

 

 

 

 

 

 

 

 

% of net sales

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

100.0%

100.0%

 

100.0%

100.0%

 

100.0%

100.0%

 

100.0%

100.0%

 

COGS

-36.9%

-37.5%

 

-47.2%

-46.7%

 

-29.1%

-30.1%

 

-33.0%

-33.7%

 

Gross profit

63.1%

62.5%

 

52.8%

53.3%

 

70.9%

69.9%

 

67.0%

66.3%

 

SG&A

-23.7%

-24.1%

 

-30.1%

-28.6%

 

-33.1%

-35.4%

 

-28.0%

-28.8%

 

Other operating income/(expenses)

-0.2%

0.2%

 

-0.4%

-0.1%

 

0.1%

-0.1%

 

5.0%

4.3%

 

Normalized EBIT

39.2%

38.6%

 

22.2%

24.6%

 

37.9%

34.4%

 

44.1%

41.8%

 

Normalized EBITDA

44.7%

44.5%

 

31.4%

33.4%

 

42.0%

37.7%

 

50.1%

48.0%

 

 

   

 

 

 

 

 

 

 

 

 

 

Per hectoliter - (R$/hl)

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

191.0

188.9

18.2%

237.6

264.0

5.7%

466.3

488.8

0.6%

210.7

221.7

7.8%

COGS

(70.6)

(70.8)

18.7%

(112.2)

(123.2)

3.9%

(135.8)

(147.0)

1.3%

(69.5)

(74.6)

9.8%

Gross profit

120.4

118.1

17.9%

125.4

140.8

7.3%

330.6

341.7

0.2%

141.2

147.1

6.8%

SG&A

(45.3)

(45.5)

21.9%

(71.6)

(75.5)

0.1%

(154.5)

(173.2)

3.9%

(58.9)

(63.9)

9.5%

Other operating income/(expenses)

(0.3)

0.3

nm

(1.0)

(0.4)

-70.7%

0.6

(0.4)

-79.8%

10.6

9.5

-8.5%

Normalized EBIT

74.8

72.9

16.7%

52.8

64.9

18.5%

176.8

168.1

-2.2%

92.9

92.7

3.3%

Normalized EBITDA

85.3

84.1

17.8%

74.6

88.2

13.7%

195.9

184.3

-3.3%

105.5

106.4

4.5%

 


 

Fourth Quarter and Full Year 2014 Results

February 26, 2015

Page 25

 

 

CONSOLIDATED BALANCE SHEET

December 2014

December 2013

R$ million

Assets

 

 

Current assets

 

 

Cash and cash equivalents

9,722.1

11,538.2

Investment securities (CURRENT)

713.0

288.6

Derivative financial instruments (current assets)

882.5

609.6

Trade receivables (current)

3,028.8

2,972.8

Inventories

3,411.3

2,835.7

Taxes and contributions receivable (current)

1,581.9

1,397.0

Other assets (current)

1,388.8

1,167.2

 

20,728.4

20,809.1

Non-current assets

 

 

Investment securities

68.0

63.8

Derivative financial instruments (assets)

5.5

1.7

Taxes and contributions receivable (non-current)

1,161.2

474.1

Deferred tax assets

1,392.5

1,647.8

Other assets (non-current)

1,736.5

1,795.5

Employee benefits

12.8

23.4

Investments in associates

40.4

26.5

Property, plant and equipment

15,740.1

14,005.6

Intangible assets

3,754.9

3,214.0

Goodwill

27,502.9

27,023.7

 

51,414.8

48,276.1

 

 

 

Total assets

72,143.2

69,085.2

 

 

 

Equity and liabilities

 

 

Current liabilities

 

 

Trade payables (current)

8,708.7

8,007.7

Derivative financial instruments (current liabilities)

1,909.2

945.6

Interest-bearing loans and borrowings (current)

988.1

1,040.6

Bank overdrafts

99.1

-

Payroll and social security payables

598.4

722.1

Dividends and interest on shareholder´s equity payable

2,435.3

1,174.2

Income tax and social contribution payable

640.4

897.1

Taxes and contributions payable (current)

2,903.3

2,235.2

Other liabilities (current)

3,403.1

2,185.2

Provisions

139.2

145.0

 

21,824.8

17,352.7

Non-current liabilities

 

 

Trade payables (non-current)

73.9

69.4

Derivative financial instruments (liabilities)

29.8

32.5

Interest-bearing loans and borrowings

1,634.6

1,865.2

Deferred tax liabilities

1,737.6

2,095.7

Taxes and contributions payable (non-current)

610.9

883.0

Other liabilities (non-current)

286.7

572.0

Provisions (non-CURRENT)

543.2

431.7

Employee benefits (non CURRENT)

1,757.0

1,558.3

 

6,673.7

7,507.8

 

 

 

Total liabilities

28,498.5

24,860.5

 

 

 

Equity

 

 

Issued capital

57,582.4

57,000.8

Reserves

59,907.2

61,220.3

Comprehensive income

(75,268.0)

(75,228.6)

Equity attributable to equity holders of Ambev

42,221.6

42,992.5

Non-controlling interests

1,423.1

1,232.2

Total Equity

43,644.7

44,224.7

 

 

 

Total equity and liabilities

72,143.2

69,085.2

 

 
 


 

Fourth Quarter and Full Year 2014 Results

February 26, 2015

Page 26

 

CONSOLIDATED STATEMENT OF OPERATIONS

 

4Q13
Reference
Base

 

FY13 Reference Base

R$ million

4Q14

FY14

 

 

 

 

 

Net sales

12,232.9

11,132.6

38,079.8

35,079.1

Cost of sales

(3,809.8)

(3,323.6)

(12,814.6)

(11,572.5)

Gross profit

8,423.0

7,809.0

25,265.2

23,506.6

 

 

 

 

 

Sales and marketing expenses

(2,336.2)

(1,964.4)

(9,158.7)

(8,059.9)

Administrative expenses

(627.5)

(635.9)

(1,820.0)

(1,748.3)

Other operating income/(expenses)

663.1

743.0

1,629.2

1,761.7

 

 

 

 

 

Normalized EBIT

6,122.5

5,951.7

15,915.6

15,460.0

 

 

 

 

 

Exceptional items

(63.2)

(16.0)

(89.0)

(29.2)

 

 

 

 

 

Income from operations (EBIT)

6,059.3

5,935.7

15,826.6

15,430.8

 

 

 

 

 

Net finance results

(587.5)

(558.9)

(1,475.4)

(1,561.4)

Share of results of associates

4.2

5.7

17.4

11.4

 

 

 

 

 

Profit before income tax

5,476.0

5,382.6

14,368.6

13,880.8

 

 

 

 

 

Income tax expense

(816.9)

(617.6)

(2,006.6)

(2,481.4)

 

 

 

 

 

Profit

4,659.1

4,764.9

12,362.0

11,399.4

Attributable to:

 

 

 

 

Equity holders of Ambev

4,538.4

4,673.7

12,065.5

9,557.3

Non-controlling interest

120.7

91.2

296.5

1,842.1

 

 

 

 

 

Nº of basic shares outstanding

15,704.3

15,661.9

15,682.9

12,677.6

Nº of diluted shares outstanding

15,841.2

15,807.7

15,819.9

12,823.5

 

 

 

 

 

Basic earnings per share (common)

0.29

0.30

0.77

0.75

Diluted earnings per share (common)

0.29

0.30

0.76

0.75

 

 

 


 

 

Fourth Quarter and Full Year 2014 Results

February 26, 2015

Page 26

 

CONSOLIDATED STATEMENT OF CASH FLOWS

 

4Q13
Reference
Base

 

FY13 Reference Base

R$ million

 

4Q14

FY14

Cash Flows from Operating Activities

 

 

 

 

 

Profit

4,659.1

4,764.9

12,362.0

11,399.4

 

 

Depreciation, amortization and impairment

710.9

522.9

2,392.5

2,105.1

 

 

Impairment losses on receivables and inventories

20.1

9.5

99.5

117.1

 

 

Additions/(reversals) in provisions and employee benefits

83.4

76.4

169.1

203.3

 

 

Net finance cost

587.5

558.9

1,475.4

1,561.4

 

 

Loss/(gain) on sale of property, plant and equipment and intangible assets

(38.8)

(7.3)

(33.9)

(24.7)

 

 

Equity-settled share-based payment expense

44.9

61.9

161.0

182.2

 

 

Income tax expense

816.9

617.6

2,006.6

2,481.4

 

 

Share of result of associates

(4.2)

(5.7)

(17.4)

(11.4)

 

 

Other non-cash items included in the profit

(23.7)

(90.2)

(320.1)

(228.1)

 

Cash flow from operating activities before changes in working capital and use of provisions

6,856.2

6,508.9

18,294.9

17,785.6

 

 

Decrease/(increase) in trade and other receivables

(435.2)

(865.1)

(502.6)

(1,178.1)

 

 

Decrease/(increase) in inventories

(215.8)

(219.9)

(589.0)

(417.6)

 

 

Increase/(decrease) in trade and other payables

2,810.8

2,990.6

1,577.4

1,279.9

 

Cash generated from operations

9,015.9

8,414.4

18,780.7

17,469.9

 

 

Interest received/(paid)

(110.1)

(6.9)

(350.2)

173.9

 

 

Dividends received

(46.1)

33.1

21.0

136.0

 

 

Income tax paid

(87.8)

(103.4)

(2,555.8)

(2,464.9)

 

Cash flow from operating activities

8,771.8

8,337.2

15,895.7

15,314.8

 

 

Proceeds from sale of property, plant, equipment and intangible assets

74.4

47.3

151.9

112.3

 

 

Acquisition of property, plant, equipment and intangible assets

(1,276.4)

(1,450.0)

(4,493.1)

(3,810.3)

 

 

Acquisition of subsidiaries, net of cash acquired

(1.6)

(9.9)

(10.7)

(254.9)

 

 

Investment in debt securities and net proceeds of debt securities

(185.0)

312.7

(445.7)

141.7

 

 

Net acquisition of other assets

0.6

0.0

29.5

 

 

Cash flow used in investing activities

(1,388.0)

(1,100.0)

(4,768.1)

(3,811.2)

 

 

Capital increase and advancement for future capital increase

7.7

(138.9)

157.6

17.4

 

 

Increase/(decrease) in capital in subsidiaries / non-controlling

 

168.3

 

172.4

 

 

Proceeds/repurchase of treasury shares

(50.5)

(28.8)

(74.2)

(37.7)

 

 

Proceeds from borrowings

514.1

138.0

1,005.2

331.4

 

 

Repayment of borrowings

(458.5)

(264.7)

(1,790.3)

(991.2)

 

 

Cash net finance costs other than interests

130.2

(664.1)

(380.9)

(1,663.8)

 

 

Payment of finance lease liabilities

(0.3)

(0.4)

(1.6)

(1.5)

 

 

Dividends paid

(3,518.7)

(196.6)

(12,059.6)

(7,333.7)

 

Cash flow used in financing activities

(3,376.1)

(987.1)

(13,143.8)

(9,506.7)

 

Net increase/(decrease) in Cash and cash equivalents

4,007.7

6,250.1

(2,016.2)

1,996.8

 

Cash and cash equivalents less bank overdrafts at beginning of period

(13,321.3)

(8,837.2)

11,538.2

9,259.3

 

Effect of exchange rate fluctuations

213.1

103.9

100.9

282.1

 

Cash and cash equivalents less bank overdrafts at end of period

(9,100.4)

(2,483.2)

9,623.0

11,538.2

 

 

 

 


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
Date: February 26, 2015

 

     
 
AMBEV S.A.
     
 
By: 
/s/ Nelson José Jamel
 
Nelson Jose Jamel
Chief Financial and Investor Relations Officer